Concepedia

Michael Steckel

MS

Statistics

Publications

8

Citations

1.6K

H-Index

8

Active since

2005

Affiliations

Bayer (Germany)(Current)

The Honourable Society of Lincoln's Inn

Cancer Research UK

Michael Steckel is an author at Bayer (Germany) specializing in molecular oncology, molecular biology, and medicine.

Publications per year

2005–2020

8

Publications

8

TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo

Jae‐Hyuck Shim, Changchun Xiao, Amber Paschal et al. · Genes & Development · 2005 · 729 citations · Full text

, , +17

The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer

Madhu Kumar, David C. Hancock, Míriam Molina‐Arcas et al. · Cell · 2012 · 267 citations · Full text

, , +12

Determination of synthetic lethal interactions in KRAS oncogene-dependent cancer cells reveals novel therapeutic targeting strategies

Michael Steckel, Míriam Molina‐Arcas, Britta Weigelt et al. · Cell Research · 2012 · 188 citations · Full text

, , +17

Metabolic pathway analyses identify proline biosynthesis pathway as a promoter of liver tumorigenesis

Zhaobing Ding, Russell Ericksen, Nathalie Escande‐Beillard et al. · Journal of Hepatology · 2019 · 144 citations

, , +16

An RNA interference screen ide.jpgies Inhibitor of Apoptosis Protein 2 as a regulator of innate immune signalling in Drosophila

Viola Gesellchen, David Kuttenkeuler, Michael Steckel et al. · EMBO Reports · 2005 · 131 citations · Full text

, , +16

1–5 of 8